USC receives $6 million grant for pioneering glioblastoma gene therapy
Revolutionary Gene Therapy: A New Horizon in Glioblastoma Treatment Glioblastoma, a formidable adversary in the realm of brain cancers, has long defied medical science, boasting a mere 5 percent five-year survival rate. Yet, hope is on the horizon, thanks to a groundbreaking gene therapy pioneered by researchers at the University of Southern California (USC). Recently … Read more